Imaging News and Research

RSS

AI tool helps customize radiopharmaceutical therapy dosing

Radiopharmaceutical therapy (RPT) has made great strides over the last 50 years, having only recently received FDA approval to treat prostate cancer. But despite the progress-and billions of dollars of industry investments-one area that has lagged behind is dosing, which is still one-size-fits-all.

4 Aug 2026

Child-friendly lung test identifies subtle abnormalities before stem cell transplant

As spirometry requires coordinated deep breathing and can be challenging for children to perform, researchers from the USA, as part of the TRANSPIRE study investigating lung complications in children undergoing hematopoietic stem cell transplantation (HSCT), explored the potential of oscillometry, a simple and child-friendly lung function test.

3 Aug 2026

New AI model generates detailed maps of aging in brain regions

USC researchers have developed an approach that uses artificial intelligence to generate detailed maps that highlight differences in how distinct parts of the brain age.

3 Aug 2026

Gut microbiome shifts may begin before Alzheimer’s symptoms appear

A narrative review links reduced SCFA-producing gut bacteria and altered microbial metabolism with Alzheimer’s disease, while early evidence suggests similar changes may appear before cognitive symptoms. Mediterranean, DASH, MIND, and prudent diets are associated with beneficial microbial profiles, but direct evidence connecting diet, the microbiome, and amyloid pathology remains limited.

3 Aug 2026

Persistent financial hardship tracks with poorer memory and processing speed by midlife

Researchers linked persistent low income and financial hardship across early and mid-adulthood to poorer processing speed and verbal memory at age 53 in a British birth cohort. Neuroimaging suggested greater vulnerability to later brain atrophy among men, people from disadvantaged childhood backgrounds, and APOE-ε4 carriers, although these subgroup findings require replication.

2 Aug 2026

AI-powered blood test detects liver cancer across distinct populations

Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and biologically distinct populations and also uncovered the underlying biological signals that make the test effective.

31 Jul 2026

Researchers uncover hierarchical sensory processing system in the zebrafish brain

How does the brain make sense of what we see, hear, and feel—and transform these separate signals into a coherent perception of the world?

31 Jul 2026

New mechanism linked to septic heart injury protection uncovered

Sepsis triggers widespread inflammation, circulatory failure and metabolic stress, and cardiac dysfunction is a common complication associated with sharply poorer outcomes.

31 Jul 2026

New research explains how embryos establish germline cell boundaries

Every embryo of an organism that reproduces sexually faces an early and consequential decision: which of its cell lineages will make up the mortal body, and which will become the germline, the lineage that eventually makes eggs or sperm and carries genetic information to the next generation.

30 Jul 2026

New ultrasound technique breaches blood brain barrier to treat gliomas

In a promising sign for the potential of focused sound waves to improve care for brain tumors, UVA Health researchers have determined that tumors called gliomas may be even more receptive to targeted drug delivery than normal brain tissue.

30 Jul 2026

Lanthanide carriers advance next generation biomedical imaging and theranostics

Lanthanide carriers could help define the next generation of biomedical imaging and fast-track the emerging field of theranostics-approaches that link diagnostic imaging with treatment selection, delivery, or monitoring.

30 Jul 2026

Qureight closes $20 million Series B financing

Qureight, an end-to-end imaging company that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, today announced it has raised $20 million in a Series B financing, led by Molten Ventures.

From Qureight 30 Jul 2026

AI tool improves motor imitation assessment for children with autism

Researchers at Kennedy Krieger Institute and Penn Engineering announcing the development of an advanced artificial intelligence system that measures a child's ability to imitate simple body movements using ordinary video recordings.

29 Jul 2026

New CapuchinAI system automates cognitive testing of wild primates

Scientists created an AI system that uses facial recognition and real-time, touchscreen testing to automate cognitive studies of capuchin monkeys in the wild.

29 Jul 2026

New method reveals three-dimensional nanoplastic distribution in neonatal mouse brains

Nanoplastics-plastic particles smaller than one micrometer-are generated through the degradation and abrasion of plastic products and are increasingly detected in food, drinking water, air, and biological tissues.

29 Jul 2026

New AI-based method could improve detection and classification of brain tumors from MRI scans

Researchers have developed a new artificial intelligence-based method that could significantly improve the detection and classification of brain tumors from MRI scans, achieving higher accuracy than conventional diagnostic systems.

29 Jul 2026

A closer look at Parkinson’s brains finds tau where standard tests saw little

Researchers used single-molecule and super-resolution imaging to profile protein aggregates across six brain regions from 29 post-mortem donors, detecting high-intensity phosphorylated tau aggregates in the Parkinson’s disease putamen despite negligible conventional tau staining. PD cases with dementia showed greater tau burden than those without dementia, while the assay did not detect a PD-specific population of nanoscopic alpha-synuclein aggregates.

29 Jul 2026

AI model predicts cancer diagnoses up to a year in advance using routine clinical data

Researchers developed Oncoformer, a multimodal transformer that analyzes longitudinal health records and chest X-rays to classify cancer, predict diagnoses up to one year in advance, infer tumor stage, and forecast treatment response and recurrence risk. Validation across large independent cohorts showed strong performance, although prospective trials in diverse, average-risk populations are needed before clinical use.

28 Jul 2026

Novel interventional approach successfully treats rare hepatic myelopathy

Hepatic myelopathy (HM) is a rare neurological complication of decompensated chronic liver disease that profoundly impairs quality of life.

28 Jul 2026

TGen joins Collaborative Research Network for Parkinson's disease research

The Translational Genomics Research Institute (TGen), part of City of Hope, today announced it has been selected as part of a national team to join the Collaborative Research Network (CRN), an international, multi-institutional initiative focused on addressing high-priority research questions in Parkinson's disease.

28 Jul 2026